MicroRNA-26a involved in Toll-like receptor 9-mediated lung cancer growth and migration

International Journal of Molecular Medicine

Volumn 34, Issue 1, 2014, Pages 307-312

  Jiang, De Sheng ^a   Wang, Yu Wei ^a   Jiang, Jing ^a   Li, Shu Meng ^a   Liang, Shun Zhi ^a   Fang, Hong Yan ^a  

^a No 454 Hospital of PLA   (China)

Author keywords

Lung cancer; microRNA 26a; Toll like receptor 9

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; MICRORNA 26A; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TOLL LIKE RECEPTOR 9; TRICIRIBINE; WORTMANNIN; ANDROSTANE DERIVATIVE; CPG-OLIGONUCLEOTIDE; MICRORNA; MIRN26A MICRORNA, HUMAN; OLIGODEOXYRIBONUCLEOTIDE; RIBONUCLEOSIDE; TLR9 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER MODEL; CANCER SIZE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; HEART LEFT VENTRICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; CANCER TRANSPLANTATION; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; NON SMALL CELL LUNG CANCER; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANDROSTADIENES; ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; MICRORNAS; NEOPLASM TRANSPLANTATION; OLIGODEOXYRIBONUCLEOTIDES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RIBONUCLEOSIDES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 9;

EID: 84902679532     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1764     Document Type: Article

References (31)

1. Gosu V, Basith S, Kwon OP and Choi S: Therapeutic applications of nucleic acids and their analogues in Toll-like receptor signaling. Molecules 17: 13503-13529, 2012.
2. Takagi M: Toll-like receptor - a potent driving force behind rheumatoid arthritis. J Clin Exp Hematop 51: 77-92, 2011.
3. Chang YJ, Wu MS, Lin JT and Chen CC: Helicobacter pylori-Induced invasion and angiogenesis of gastric cells is mediated by cyclooxygenase-2 induction through TLR2/TLR9 and promoter regulation. J Immunol 175: 8242-8252, 2005.
4. Eiró N1, Altadill A, Juárez LM, et al: Toll-like receptors 3, 4 and 9 in hepatocellular carcinoma: Relationship with clinicopathological characteristics and prognosis. Hepatol Res: Jun 6, 2013 (Epub ahead of print).
5. Zhang L, Qin H, Guan X, Zhang K and Liu Z: The TLR9 gene polymorphisms and the risk of cancer: evidence from a meta-analysis. PLoS One 8: e71785, 2013.
6. Sorrentino R, Morello S, Giordano MG, et al: CpG-ODN increases the release of VEGF in a mouse model of lung carcinoma. Int J Cancer 128: 2815-2822, 2011.
7. Droemann D, Albrecht D, Gerdes J, et al: Human lung cancer cells express functionally active Toll-like receptor 9. Respir Res 6: 1, 2005.
8. Belmont L, Rabbe N, Antoine M, et al: Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer. Int J Cancer 134: 765-777, 2014.
9. Ren T, Wen ZK, Liu ZM, Liang YJ, Guo ZL and Xu L: Functional expression of TLR9 is associated to the metastatic potential of human lung cancer cell: functional active role of TLR9 on tumor metastasis. Cancer Biol Ther 6: 1704-1709, 2007. (Pubitemid 351590304)
10. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
11. Lee RC, Feinbaum RL and Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854, 1993. (Pubitemid 24014542)
12. Cuellar TL and McManus MT: MicroRNAs and endocrine biology. J Endocrinol 187: 327-332, 2005. (Pubitemid 43020253)
13. Krol J, Loedige I and Filipowicz W: The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11: 597-610, 2010.
14. Miller AM, Gilchrist DS, Nijjar J, et al: MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice. PLoS One 8: e72324, 2013.
15. Ma Y, Bao-Han W, Lv X, et al: MicroRNA-34a mediates the autocrine signaling of PAR2-activating proteinase and its role in colonic cancer cell proliferation. PLoS One 8: e72383, 2013.
16. Yang X, Du WW, Li H, et al: Both mature miR-17-5p and passenger strand miR-17-3p target TIMP3 and induce prostate tumor growth and invasion. Nucleic Acids Res 41: 9688-9704, 2013.
17. Qian X, Zhao P, Li W, et al: MicroRNA-26a promotes tumor growth and angiogenesis in glioma by directly targeting prohibitin. CNS Neurosci Ther 19: 804-812, 2013.
18. Zhang J, Han C and Wu T: MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin. Gastroenterology 143: 246-256 e248, 2012.
19. Savry A, Carre M, Berges R, et al: Bcl-2-enhanced efficacy of microtubule-targeting chemotherapy through Bim overexpression: implications for cancer treatment. Neoplasia 15: 49-60, 2013.
20. Bhattacharya D and Yusuf N: Expression of Toll-like receptors on breast tumors: taking a toll on tumor microenvironment. Int J Breast Cancer 2012: 716564, 2012.
21. He W, Liu Q, Wang L, Chen W, Li N and Cao X: TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Mol Immunol 44: 2850-2859, 2007. (Pubitemid 46412506)
22. Min R, Zun Z, Siyi L, et al: Increased expression of Toll-like receptor-9 has close relation with tumour cell proliferation in oral squamous cell carcinoma. Arch Oral Biol 56: 877-884, 2011.
23. Esquela-Kerscher A and Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269, 2006.
24. Majumder S and Jacob ST: Emerging role of microRNAs in drug-resistant breast cancer. Gene Expr 15: 141-151, 2011.
25. Minguez B and Lachenmayer A: Diagnostic and prognostic molecular markers in hepatocellular carcinoma. Dis Markers 31: 181-190, 2011.
26. Chen R, Alvero AB, Silasi DA, et al: Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells. Oncogene 27: 4712-4723, 2008.
27. Wendlandt EB, Graff JW, Gioannini TL, McCaffrey AP and Wilson ME: The role of microRNAs miR-200b and miR-200c in TLR4 signaling and NF-κB activation. Innate Immun 18: 846-855, 2012.
28. Chen R, Alvero AB, Silasi DA, Steffensen KD and Mor G: Cancers take their Toll - the function and regulation of Toll-like receptors in cancer cells. Oncogene 27: 225-233, 2008.
29. Xu L, Zhou Y, Liu Q, et al: CXCR4/SDF-1 pathway is crucial for TLR9 agonist enhanced metastasis of human lung cancer cell. Biochem Biophys Res Commun 382: 571-576, 2009.
30. Tserel L, Runnel T, Kisand K, et al: MicroRNA expression profiles of human blood monocyte-derived dendritic cells and macrophages reveal miR-511 as putative positive regulator of Toll-like receptor 4. J Biol Chem 286: 26487-26495, 2011.
31. Chen X, Zhou JY, Zhao J, Chen JJ, Ma SN and Zhou JY: Crizotinib overcomes hepatocyte growth factor-mediated resistance to gefitinib in EGFR-mutant non-small-cell lung cancer cells. Anticancer Drugs 24: 1039-1046, 2013.